Calida Holding AG (0QP3)
London Exchange · UK · prices in CHF · close of 23 Oct 2026
Key indicators
| Last close | CHF 13.36 |
|---|---|
| 52-week range | 11.28 – 20.25 |
| Return, 1 month / 3 months | −1.8% / −23.7% |
| Return, 1 year / 3 years | −1.6% / −45.8% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 39.6% |
| Worst drawdown (1 year) | -35.5% |
| Average daily value traded | 0.02M CHF |
| Dividend yield | 1.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Calida Holding AG is a Swiss company based in Sursee that designs and sells underwear, lingerie and sleepwear for women, men and children. Its products are sold under its own brands through department stores, specialist retailers and its own shops in Switzerland and other European markets. The group also includes the French lingerie brand Aubade and the Lafuma outdoor equipment business, giving it a broader range of clothing and leisure goods for consumers.
Calida Holding AG trades under the code 0QP3 on the London Exchange in UK, with its price quoted in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Calida Holding AG (0QP3) trades on the London Exchange in UK. It last closed at CHF 13.36 on 23 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 3,090 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.6% and over the last three months it fell 23.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.1% | ||
| From 52-week high | -33.3% | ||
| Momentum | 26 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -23.7% | ||
| 6-month return | -17.6% | ||
| 12-month return, skipping the last month | 0.3% | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.5% | ||
| Liquidity | 19 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.9% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −5.1% |
|---|---|
| 1 month | −1.8% |
| 3 months | −23.7% |
| 6 months | −17.6% |
| 1 year | −1.6% |
| 3 years | −45.8% |
| 5 years | −70.4% |
Signals
| 50-day / 200-day average | 13.87 / 14.69 |
|---|---|
| Golden / death cross (60 days) | Death, 18 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Apr 2026 | CHF 0.2500 |
| 14 Apr 2025 | CHF 0.1836 |
| 10 Apr 2024 | CHF 0.3000 |
| 25 Apr 2023 | CHF 0.5500 |
| 20 Apr 2022 | CHF 1.0000 |
| 21 Apr 2021 | CHF 0.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.